CervoMed to Participate in Upcoming Investor Conferences
CervoMed Inc. (NASDAQ: CRVO), a clinical stage company developing treatments for age-related neurologic disorders, has announced its participation in two upcoming investor conferences in September 2024:
1. Morgan Stanley 22nd Annual Global Healthcare Conference: A fireside chat on Friday, September 6, 2024, at 1:50 PM ET.
2. H.C. Wainwright 26th Annual Global Investment Conference: A corporate presentation on Wednesday, September 11, 2024, at 8:30 AM ET.
Webcasts of both presentations will be available on the CervoMed website's Investor section. These conferences provide an opportunity for CervoMed to showcase its progress and engage with potential investors.
CervoMed Inc. (NASDAQ: CRVO), una azienda in fase clinica che sviluppa trattamenti per disturbi neurologici legati all'età, ha annunciato la sua partecipazione a due imminenti conferenze per investitori a settembre 2024:
1. 22ª Conferenza Annuale Globale sulla Sanità di Morgan Stanley: Un incontro informale venerdì 6 settembre 2024, alle 13:50 ET.
2. 26ª Conferenza Annuale Globale sugli Investimenti di H.C. Wainwright: Una presentazione aziendale mercoledì 11 settembre 2024, alle 8:30 ET.
Le trasmissioni web di entrambe le presentazioni saranno disponibili nella sezione Investitori del sito web di CervoMed. Queste conferenze offrono l'opportunità a CervoMed di mostrare i suoi progressi e interagire con potenziali investitori.
CervoMed Inc. (NASDAQ: CRVO), una empresa en etapa clínica que desarrolla tratamientos para trastornos neurológicos relacionados con la edad, ha anunciado su participación en dos próximas conferencias para inversores en septiembre de 2024:
1. 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley: Una charla informal el viernes 6 de septiembre de 2024, a la 1:50 PM ET.
2. 26ª Conferencia Anual Global de Inversiones de H.C. Wainwright: Una presentación corporativa el miércoles 11 de septiembre de 2024, a las 8:30 AM ET.
Las retransmisiones en vivo de ambas presentaciones estarán disponibles en la sección de Inversores del sitio web de CervoMed. Estas conferencias brindan una oportunidad para que CervoMed muestre su progreso e interactúe con posibles inversores.
CervoMed Inc. (NASDAQ: CRVO), 노화 관련 신경 질환 치료제를 개발하는 임상 단계 회사는 2024년 9월에 열리는 두 차례의 투자자 회의에 참여한다고 발표했습니다:
1. 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스: 2024년 9월 6일 금요일, 오후 1시 50분 ET에 진행되는 파이어사이드 챗.
2. H.C. 웨인라이트 제26회 글로벌 투자 컨퍼런스: 2024년 9월 11일 수요일, 오전 8시 30분 ET에 진행되는 기업 발표.
두 발표의 웹캐스트는 CervoMed 웹사이트의 투자자 섹션에서 확인할 수 있습니다. 이러한 회의는 CervoMed가 진행 상황을 시연하고 잠재 투자자들과 소통할 수 있는 기회를 제공합니다.
CervoMed Inc. (NASDAQ: CRVO), une société en phase clinique développant des traitements pour les troubles neurologiques liés à l'âge, a annoncé sa participation à deux conférences pour investisseurs à venir en septembre 2024 :
1. 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley : Un entretien informel le vendredi 6 septembre 2024, à 13h50 ET.
2. 26ème Conférence Annuelle Mondiale sur l'Investissement de H.C. Wainwright : Une présentation d'entreprise le mercredi 11 septembre 2024, à 8h30 ET.
Les rediffusions des deux présentations seront disponibles dans la section Investisseurs du site web de CervoMed. Ces conférences offrent à CervoMed l'opportunité de mettre en avant ses progrès et d'interagir avec des investisseurs potentiels.
CervoMed Inc. (NASDAQ: CRVO), ein Unternehmen in der klinischen Phase, das Behandlungen für altersbedingte neurologische Erkrankungen entwickelt, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben:
1. 22. Jährliche Globale Gesundheitskonferenz von Morgan Stanley: Ein informelles Gespräch am Freitag, den 6. September 2024, um 13:50 Uhr ET.
2. 26. Jährliche Globale Investorenkonferenz von H.C. Wainwright: Eine Unternehmenspräsentation am Mittwoch, den 11. September 2024, um 8:30 Uhr ET.
Webcasts beider Präsentationen sind im Investorenbereich der CervoMed-Website verfügbar. Diese Konferenzen bieten CervoMed die Gelegenheit, seine Fortschritte zu präsentieren und mit potenziellen Investoren in Kontakt zu treten.
- None.
- None.
BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that the Company’s management will participate in the following investor conferences during the month of September:
Morgan Stanley 22nd Annual Global Healthcare Conference
Format: Fireside Chat
Date: Friday, September 6, 2024
Time: 1:50 PM ET
Webcast Link: click here
H.C. Wainwright 26th Annual Global Investment Conference
Format: Corporate Presentation
Date: Wednesday, September 11, 2024
Time: 8:30 AM ET
Webcast Link: click here
The webcast of these presentations will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/.
About CervoMed
CervoMed Inc. (the “Company”) is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is currently developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that causes disease in DLB and certain other major neurological disorders. Neflamapimod is currently being evaluated in a Phase 2b study in patients with early-stage DLB.
Investor Contact:
PJ Kelleher
LifeSci Advisors
Investors@cervomed.com
617-430-7579
FAQ
When is CervoMed (CRVO) participating in the Morgan Stanley Global Healthcare Conference?
What type of presentation will CervoMed (CRVO) give at the H.C. Wainwright Global Investment Conference?
Where can investors access the webcasts of CervoMed's (CRVO) conference presentations?
What is the focus of CervoMed's (CRVO) clinical research?
